Related Experiment Video
Updated: Feb 10, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
miR-130 aggravates acute myocardial infarction-induced myocardial injury by targeting PPAR-γ
Xianglin Chu1, Yiqing Wang1, Liewen Pang1
1Department of Cardiothoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Abstract:
Cardiac remodeling is a common pathophysiological change associated with acute myocardial infarction (AMI). Recent evidence indicates that microRNAs are strong posttranscriptional regulators which play an important role in regulating the microenvironment of myocardial tissue after AMI. In this study, we sought to explore the potential role and underlying mechanism of miR-130 in AMI. H9c2 cells were cultured under hypoxic conditions to simulate myocardial infarction. The influence of aberrantly expressed miR-130 on H9c2 cells under hypoxia was also estimated with RT-PCR, western blot and enzyme-linked immunosorbent assay. Using bioinformatics methods, of miR-130 target genes were verified with luciferase reporter assay. Then, the effects of miR-130 on AMI were identified in an induced myocardial injury model in rats. The results show that miR-130 downregulation remarkably decreased hypoxia-induced inflammation and fibrosis related protein expression in H9c2 cells and reversed hypoxia-induced peroxisome proliferator-activated receptor γ (PPAR-γ) inhibition. A bifluorescein reporter assay further confirmed that PPAR-γ was a target gene of miR-130. This study verified that PPAR-γ has a cardioprotective effect by inhibiting NFκB-mediated inflammation and TGF-β1-mediated fibrosis. In vivo experiments confirmed that downregulation of miR-130 expression promotes PPAR-γ-mediated cardioprotective effects by suppressing inflammation and myocardial fibrosis. Taken together, these findings suggest that miR-130 knockdown alleviates infarction-induced myocardial injury by promoting PPAR-γ expression.
Insights
Downregulating miR-130 alleviates myocardial injury after infarction by increasing peroxisome proliferator-activated receptor γ (PPAR-γ) expression. This reduces inflammation and fibrosis, offering a potential therapeutic strategy for acute myocardial infarction (AMI).
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- MicroRNA Therapeutics
Background:
- Cardiac remodeling is a key pathological change following acute myocardial infarction (AMI).
- MicroRNAs are critical posttranscriptional regulators influencing myocardial tissue post-AMI.
- The specific role of miR-130 in AMI pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the role and mechanism of miR-130 in acute myocardial infarction (AMI).
- To explore the potential of targeting miR-130 for therapeutic intervention in myocardial injury.
Main Methods:
- Utilized H9c2 cells under hypoxia to simulate myocardial infarction.
- Employed RT-PCR, Western blot, and ELISA to assess miR-130's effects.
- Verified miR-130 targets using bioinformatics and luciferase reporter assays.
- Confirmed findings in a rat model of induced myocardial injury.
Main Results:
- miR-130 downregulation reduced hypoxia-induced inflammation and fibrosis in H9c2 cells.
- miR-130 inhibition reversed hypoxia-induced suppression of peroxisome proliferator-activated receptor γ (PPAR-γ).
- PPAR-γ was confirmed as a direct target of miR-130, mediating cardioprotection by inhibiting NFκB and TGF-β1.
- In vivo studies showed miR-130 knockdown enhanced PPAR-γ's protective effects against myocardial injury.
Conclusions:
- miR-130 knockdown alleviates infarction-induced myocardial injury.
- The mechanism involves promoting PPAR-γ expression, which suppresses inflammation and fibrosis.
- Targeting miR-130 represents a promising therapeutic strategy for acute myocardial infarction.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

